Sensitive bromatometric assay methods for finasteride in pharmaceuticals

Main Article Content

Basavaiah Kanakapura
Bankavadi Chikkaswamy Somashekar
Urdigere Rangachar Anilkumar
Veeraiah Ramakrishna

Abstract

Three sensitive spectrophotometric methods are presented for the determination of finas-
teride in bulk and in tablets. The methods rely on the use of bromate-bromide reagent and three dyes
namely, methyl orange, indigocarmine and thymol blue as reagents. They involve the addition of a
measured excess of bromate-bromide reagent to finasteride in acid medium, and after the bromination
reaction is judged to be complete, the unreacted bromine is determined by reacting with a fixed amount
of either methylorange and measuring the absorbance at 520 nm (method A) or indigocarmine and
measuring the absorbance at 610 nm (method B) or thymol blue and measuring the absorbance at 550
nm (method C). In all the methods, the amount of insitu generated bromine reacted corresponds to the
amount of finasteride. The absorbance measured at the respective wavelength is found increase linear-
ly with the concentration of finasteride. Beer’s law is obeyed in the ranges 0.25- 2.0, 0.5-6.0 and 1-12
μg mL -1 for method A, method B and method C, respectively.

Metrics

Metrics Loading ...

Article Details

How to Cite
Kanakapura, B., Somashekar, B. C., Anilkumar, U. R., & Ramakrishna, V. (2006). Sensitive bromatometric assay methods for finasteride in pharmaceuticals. Eclética Química, 31(3), 31–38. https://doi.org/10.26850/1678-4618eqj.v31.3.2006.p31-38
Section
Original articles

References

The Merck Index, 12 th Edn., Merck and Co. Inc, White

House Station. N J, 691, (1994).

Current Index of Medical Specialities (CIMS), Updated

Prescriber’s Hand Book, July-October 2005, PP.288,

CMPMedia India Pvt. Ltd., Bangalore, India.

G. Carlucci, P. Mazzeo, J. Chromatogr.-B: Biomed. Appl.

(1997) 245.

B.K. Matuszewski, M.L. Constanzer, C.M. Chavez-Eng.,

Anal. Chem. 70 (1998) 882.

T. Takano, S. Hata, J. Chromatogr. B: Biomed. Appl. 676

(1996) 141.

M.L. Constanzer, C.M. Chavez, B.K. Matuszewski, J.

Chromatogr. B: Biomed. Appl. 658 (1994) 281.

Yuquin, Y. Yang, L. Huichen, Yaowu Fenxi Zazhi 25 (2005)

X. Yuquing, L.Yanyan, Zhongguo Yaoke Daxue Xuebao 35

(2004) 187.

Zhiyong, C. Xiaoyan, Z.Yifan, Z. Dafang, Zhongguo

Linchuang Yaolixue Zazhi 19 (2003) 196.

L. Xiangyang, D, Li, L. Limin, Yaoxue Xuebao, 38 (2003)

P. Ptacek, J. Macek, J. Klima, J. Chromatogr, B: Biomed.

Sci. Appl., 738 (2000) 305.

L. Xiyang, C. Yifeng, C. Wansheng, Z. Bin, Z. Dong

Liang, Yaowu Fenxi Zazhi, 23 (2003) 46.

X. Mufeng, Zhongguo Yiyao Gongye Zazhi, 33 (2002)

M. F. Vitate, V.L. Perez, M. L. Palacios, M. T. Pizzorno, J.

Liq. Chromatogr. Relat. Technol., 25 (2002) 3167.

L. Xin-yuan, S. Yu-xin, Hebei Gongue Daxue Xuebao, 30

(2001) 66.

D. Hulya, C. Aysen, S. Serap, Anal. Chimica Acta, 557(1-

(2006) 252.

Z. Li, L. Luosheng, L. Fengli, Yaowu Fenxi Zazhi, 22

(2002) 456.

H. Rongfeng, F. Zhiying, W. Jian, S. Song, Zhongguo

Yiyuan Yaoxue, 22 (2002) 287.

A. A. Syed, M. K. Amshumali, J. Pharm. Biomed. Anal.,

(2001) 1015.

K. Ilango, P. Valentina, K.S.Lakshmi, Indian Drugs, 40

(2003) 122.

S. N. Meyyanathan, G.V.S. Ramasarma, B. Suresh, J.

Planar Chromatogr-Mod. TLC., 14 (2001) 188.

J.A. Ryan, S.V. Compton, M.A. Brooks, D.A.C.Compton,

J. Pharm. Biomed. Anal., 9 (1991) 303.

S.M. Amer, Farmaco, 58 (2003) 159.

Martindale, The Extrapharmacopoeia, 30th Edn; The

pharmaceutical Press London. (1994) 691

The United States of Pharmacopeia. United States

Pharamcopoeial Convention Inc., Rockville. 29 (2005) 907.

K. Ilango, P. Valentina, K.S. Lakshmi; Indian J. Pharm.

Sci., 64, (2002).174.

K. Basavaiah, H.C. Prameela, Science Asia, 29 (2003)

K. Basavaiah, H.C. Prameela, Anal. Bioanal.Chem., 29

(2003) 25.

Planar Chromatogr-Mod. TLC., 14 (2001) 188.

J.A. Ryan, S.V. Compton, M.A. Brooks, D.A.C.Compton,

J. Pharm. Biomed. Anal., 9 (1991) 303.

S.M. Amer, Farmaco, 58 (2003) 159.

Martindale, The Extrapharmacopoeia, 30th Edn; The

pharmaceutical Press London. (1994) 691

The United States of Pharmacopeia. United States

Pharamcopoeial Convention Inc., Rockville. 29 (2005) 907.

K. Ilango, P. Valentina, K.S. Lakshmi; Indian J. Pharm.

Sci., 64, (2002).174.

K. Basavaiah, H.C. Prameela, Science Asia, 29 (2003)

K. Basavaiah, H.C. Prameela, Anal. Bioanal.Chem., 29

(2003) 25.

K. Basavaiah, U. Chadrashekar, Acta Ciencia Indica

Chem., 29 (2003) 25.

. K. Basavaiah, P. Nagegowda, IL Farmaco, 59 (2004) 147.

. K. Basavaiah, P. Nagegowda, Oxid. Commun., 27 (2004)

. K. Basavaiah, H.C. Prameela, Indian J. Pharm. Sci., 67

(2004) 883.

. K. Basavaiah, Indian J. Chem. Technol., 12 (2005) 149.

. K. Basavaiah, P. Nagegowda, J. Braz. Chem. Soc., 16

(2005) 821.

. K. Basavaiah, B.C. Somashekar, Indian J. Chem.

Technol., 12 (2006) 316.

. Text on Validation of Analytical Procedures, ICH

Harmonized Tripartite Guideline,6. (1994).